
Indication
Lowering IOP in chronic open-angle glaucoma or ocular hypertension

Mechanism of Action
Levobunolol is a noncardioselective beta-blocker. It lowers intraocular pressure (IOP) by decreasing aqueous humor production. This is achieved through the inhibition of beta-adrenergic receptors in the ciliary body, reducing cAMP levels and subsequently decreasing aqueous humor formation.

Available Quantities
5 ml, 10 ml, 15 ml

Dosage/Instructions
0.5%: 1 or 2 drops in the morning to start, twice daily maximum. 0.25%: 1 or 2 drops twice daily.

Pregnancy & Nursing
Use cautiously during pregnancy. No adequate and well-controlled studies in pregnant women.

Pediatric Use
No studies

Contraindications, side effects, etc.
Contraindicated in asthma, severe COPD, sinus bradycardia, AV block, cardiac failure, cardiogenic shock, hypersensitivity. Warnings include systemic absorption risks, cardiac failure, vascular insufficiency, obstructive pulmonary disease, diabetes mellitus, thyrotoxicosis, choroidal detachment. Adverse reactions: ocular burning, stinging, blepharoconjunctivitis, heart rate and blood pressure decrease, iridocyclitis, headache, ataxia, dizziness, lethargy, urticaria, pruritus.